Executive leader with 30 years in the Pharmaceutical Industry in development, regulatory and quality roles. Core technical capabilities include technical knowledge and capability in cell line and cell product development, process and product development of recombinant proteins, and analytics associated with large molecule products. Core leadership capabilities include good collaborator within complex organizations and among a variety of stakeholders; drive to get things done; deep and broad Subject Matter Expert who thinks quickly and comprehensively; decisive, displays perseverance and pragmatism; develops talent by identifying individuals’ strengths and empowering them; passionate about mission and work. Specialties: Expert in quality requirements for recombinant biotechnology products and emerging cellular therapies; quality system and compliance expert; knowledgeable in process and product quality registration requirements world-wide; in-depth knowledge of process and analytical characterization of recombinant biotechnology products and emerging cellular therapies.
Chief Technical Officer at Kyverna Therapeutics